Islet Oxygen Consumption Rate (OCR) Dose Predicts Insulin Independence in Clinical Islet Autotransplantation
Open Access
- 10 August 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (8) , e0134428
Abstract
Reliable in vitro islet quality assessment assays that can be performed routinely, prospectively, and are able to predict clinical transplant outcomes are needed. In this paper we present data on the utility of an assay based on cellular oxygen consumption rate (OCR) in predicting clinical islet autotransplant (IAT) insulin independence (II). IAT is an attractive model for evaluating characterization assays regarding their utility in predicting II due to an absence of confounding factors such as immune rejection and immunosuppressant toxicity. Membrane integrity staining (FDA/PI), OCR normalized to DNA (OCR/DNA), islet equivalent (IE) and OCR (viable IE) normalized to recipient body weight (IE dose and OCR dose), and OCR/DNA normalized to islet size index (ISI) were used to characterize autoislet preparations (n = 35). Correlation between pre-IAT islet product characteristics and II was determined using receiver operating characteristic analysis. Preparations that resulted in II had significantly higher OCR dose and IE dose (pIE dose and 0.96 for OCR dose). FDA/PI (AUC = 0.49) and OCR/DNA (AUC = 0.58) did not correlate with II. OCR/DNA/ISI may have some utility in predicting outcome (AUC = 0.72). Commonly used assays to determine whether a clinical islet preparation is of high quality prior to transplantation are greatly lacking in sensitivity and specificity. While IE dose is highly predictive, it does not take into account islet cell quality. OCR dose, which takes into consideration both islet cell quality and quantity, may enable a more accurate and prospective evaluation of clinical islet preparations.Keywords
This publication has 30 references indexed in Scilit:
- Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010Diabetes Care, 2012
- Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 DiabetesAmerican Journal of Transplantation, 2012
- Similar Islet Function in Islet Allotransplant and Autotransplant Recipients, Despite Lower Islet Mass in AutotransplantsTransplantation, 2011
- Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation BlockadeTransplantation, 2010
- Experience with a Novel Efalizumab‐Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell TransplantationAmerican Journal of Transplantation, 2010
- Islet assessment for transplantationCurrent Opinion in Organ Transplantation, 2009
- Human Islet Isolation for Autologous Transplantation: Comparison of Yield and Function Using SERVA/Nordmark Versus Roche EnzymesAmerican Journal of Transplantation, 2009
- Islet Autotransplant Outcomes After Total Pancreatectomy: A Contrast to Islet Allograft OutcomesTransplantation, 2008
- Characterization of Islet Preparations2007
- Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graftProceedings of the National Academy of Sciences, 2006